Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2017-09-08 16:31:51 UTC |
---|
Update Date | 2022-11-30 19:24:24 UTC |
---|
HMDB ID | HMDB0112154 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | FAHFA(16:1(9Z)/5-O-16:0) |
---|
Description | Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:1(9Z)/5-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitoleic acid with the hydroxy group of 5-hydroxyhexadecanoic acid. It is alternatively named 5-POHPA since it is the 5-hydroxy isomer of the POHPA (palmitoleic acid-hydroxypalmitic acid) family. |
---|
Structure | [H]\C(CCCCCC)=C(/[H])CCCCCCCC(=O)OC(CCCCCCCCCCC)CCCC(O)=O InChI=1S/C32H60O4/c1-3-5-7-9-11-13-14-15-16-18-20-22-24-29-32(35)36-30(27-25-28-31(33)34)26-23-21-19-17-12-10-8-6-4-2/h13-14,30H,3-12,15-29H2,1-2H3,(H,33,34)/b14-13- |
---|
Synonyms | Value | Source |
---|
5-POHPA | SMPDB, HMDB | 5-(palmitoleoyloxy)hexadecanoic acid | SMPDB, HMDB | 5-(palmitoleoyloxy)palmitic acid | SMPDB, HMDB | palmitoleic acid-5-hydroxypalmitic acid | SMPDB, HMDB | FAHFA(16:1(9Z)/5-O-16:0) | SMPDB |
|
---|
Chemical Formula | C32H60O4 |
---|
Average Molecular Weight | 508.828 |
---|
Monoisotopic Molecular Weight | 508.449160412 |
---|
IUPAC Name | 5-[(9Z)-hexadec-9-enoyloxy]hexadecanoic acid |
---|
Traditional Name | 5-[(9Z)-hexadec-9-enoyloxy]hexadecanoic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | [H]\C(CCCCCC)=C(/[H])CCCCCCCC(=O)OC(CCCCCCCCCCC)CCCC(O)=O |
---|
InChI Identifier | InChI=1S/C32H60O4/c1-3-5-7-9-11-13-14-15-16-18-20-22-24-29-32(35)36-30(27-25-28-31(33)34)26-23-21-19-17-12-10-8-6-4-2/h13-14,30H,3-12,15-29H2,1-2H3,(H,33,34)/b14-13- |
---|
InChI Key | SVLKUGBXYAQXIT-YPKPFQOOSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Fatty Acyls |
---|
Sub Class | Fatty acids and conjugates |
---|
Direct Parent | Long-chain fatty acids |
---|
Alternative Parents | |
---|
Substituents | - Long-chain fatty acid
- Fatty acid ester
- Dicarboxylic acid or derivatives
- Carboxylic acid ester
- Carboxylic acid
- Carboxylic acid derivative
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | Not Available |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - FAHFA(16:1(9Z)/5-O-16:0) GC-MS (1 TMS) - 70eV, Positive | splash10-05dr-7944570000-0b6aadf97fecbe7d790a | 2017-10-06 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - FAHFA(16:1(9Z)/5-O-16:0) 10V, Positive-QTOF | splash10-052f-0060920000-7e71f4ff696db2f53edc | 2019-02-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - FAHFA(16:1(9Z)/5-O-16:0) 20V, Positive-QTOF | splash10-0a4r-1290200000-c4e2e5ad92fae3938be2 | 2019-02-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - FAHFA(16:1(9Z)/5-O-16:0) 40V, Positive-QTOF | splash10-0006-3790200000-518fc6cd650e555c5f63 | 2019-02-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - FAHFA(16:1(9Z)/5-O-16:0) 10V, Negative-QTOF | splash10-0a4i-0060390000-3a433e817125cd9a206f | 2019-02-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - FAHFA(16:1(9Z)/5-O-16:0) 20V, Negative-QTOF | splash10-0pi9-1090310000-7d45a3855ba078f3e8f5 | 2019-02-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - FAHFA(16:1(9Z)/5-O-16:0) 40V, Negative-QTOF | splash10-0pdl-5190000000-f47443f7ff4e6e990e3f | 2019-02-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - FAHFA(16:1(9Z)/5-O-16:0) 10V, Negative-QTOF | splash10-0a4i-0000090000-77bf28fa9c0b252662b8 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - FAHFA(16:1(9Z)/5-O-16:0) 20V, Negative-QTOF | splash10-0a4i-0000090000-77bf28fa9c0b252662b8 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - FAHFA(16:1(9Z)/5-O-16:0) 40V, Negative-QTOF | splash10-14vk-0490040000-d27ac3a711d92edebc03 | 2021-09-24 | Wishart Lab | View Spectrum |
|
---|
General References | - Yore MM, Syed I, Moraes-Vieira PM, Zhang T, Herman MA, Homan EA, Patel RT, Lee J, Chen S, Peroni OD, Dhaneshwar AS, Hammarstedt A, Smith U, McGraw TE, Saghatelian A, Kahn BB: Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects. Cell. 2014 Oct 9;159(2):318-32. doi: 10.1016/j.cell.2014.09.035. [PubMed:25303528 ]
|
---|